Tekla Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Tekla Healthcare Investors
HQH Stock  USD 19.89  0.30  1.53%   
Tekla Healthcare's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Tekla Healthcare's valuation are provided below:
Gross Profit
7.5 M
Profit Margin
13.0902
Market Capitalization
1.1 B
Enterprise Value Revenue
11.0616
Revenue
7.5 M
We have found one hundred fifteen available fundamental trend indicators for Tekla Healthcare Investors, which can be analyzed and compared to other ratios and to its competition. Traders should compare all of Tekla Healthcare Investors current fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The Tekla Healthcare's current Market Cap is estimated to increase to about 1 B. The Tekla Healthcare's current Enterprise Value is estimated to increase to about 1 B

Tekla Healthcare Total Revenue

120.52 Million

Check Tekla Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tekla Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 188.3 K, Interest Expense of 0.0 or Selling General Administrative of 1.3 M, as well as many indicators such as Price To Sales Ratio of 174, Dividend Yield of 0.0762 or PTB Ratio of 1.0. Tekla financial statements analysis is a perfect complement when working with Tekla Healthcare Valuation or Volatility modules.
  
Build AI portfolio with Tekla Stock
Check out the analysis of Tekla Healthcare Correlation against competitors.

Tekla Healthcare Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets708.4 M1.3 B928.2 M
Slightly volatile
Other Current Liabilities1.9 M1.3 M1.4 M
Slightly volatile
Total Current Liabilities1.3 M1.4 M6.2 M
Pretty Stable
Total Stockholder Equity702.9 M1.3 B921.4 M
Slightly volatile
Non Current Assets Total710.6 M1.3 B907.5 M
Slightly volatile
Cash And Short Term Investments50.4553.1652.3 K
Pretty Stable
Common Stock Total Equity479.3 K504.5 K307 M
Slightly volatile
Common Stock Shares Outstanding32.2 M61.7 M40.2 M
Slightly volatile
Liabilities And Stockholders Equity708.4 M1.3 B928.2 M
Slightly volatile
Total Liabilities5.5 M3.9 M6.7 M
Very volatile
Total Current Assets2.9 M3 M20.8 M
Pretty Stable
Common Stock606.5 K638.4 K307 M
Slightly volatile
Net Receivables3 M2.9 M3.3 M
Pretty Stable
Net Tangible Assets962.8 M1.1 B972.3 M
Pretty Stable
Retained Earnings144.7 M91.4 M219.3 M
Slightly volatile
Accounts Payable1.3 M1.4 M6.6 M
Slightly volatile
Long Term Investments985.5 M1.3 B991.5 M
Slightly volatile
Other Liabilities25.1 K36.1 K30.3 K
Slightly volatile
Other Current Assets64.4 K67.8 K23.4 M
Slightly volatile
Capital Stock474.6 K499.6 K416.2 M
Slightly volatile
Short Term Investments26.2 M37.6 M22.1 M
Slightly volatile
Inventory23324519.9 M
Slightly volatile
Short and Long Term Debt Total7.3 M9.8 M3.7 M
Slightly volatile
Capital Surpluse917.4 M981.3 M841.9 M
Slightly volatile

Tekla Healthcare Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization188.3 K198.2 K6.6 M
Slightly volatile
Selling General Administrative1.3 M1.3 M4.1 M
Slightly volatile
Other Operating Expenses1.3 M1.4 M24.3 M
Slightly volatile
Cost Of Revenue7.4 M12.1 M9.3 M
Slightly volatile
Total Operating Expenses1.3 M1.4 M24.2 M
Slightly volatile
Interest Income856.2 K901.2 K63.5 M
Slightly volatile
Net Interest Income622.7 K1.2 M414.2 K
Slightly volatile
Research Development0.480.51.4606
Slightly volatile
Selling And Marketing Expenses45.1 K50.8 K55.4 K
Slightly volatile

Tekla Healthcare Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow234246218.6 K
Very volatile
End Period Cash Flow234246213.9 K
Very volatile
Sale Purchase Of Stock67.1 M92.2 M77.8 M
Slightly volatile
Investments25 M27.3 M23.8 M
Slightly volatile
Total Cashflows From Investing Activities25 M27.3 M23.8 M
Slightly volatile
Change To Operating Activities84.1 K80.1 K83.3 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio17489.35129
Very volatile
Dividend Yield0.07620.130.1007
Very volatile
PTB Ratio1.00.910.9166
Very volatile
Days Sales Outstanding18.3519.32204
Pretty Stable
Book Value Per Share26.0723.3723.2371
Very volatile
Average Payables6.1 M6.5 M13 M
Slightly volatile
PB Ratio1.00.910.9166
Very volatile
EV To Sales17489.35129
Very volatile
Sales General And Administrative To Revenue1.941.171.428
Pretty Stable
Cash Per Share0.00.00.012
Very volatile
Current Ratio0.470.56.6458
Very volatile
Tangible Book Value Per Share26.0723.3723.2371
Very volatile
Receivables Turnover20.5319.5616.2511
Slightly volatile
Graham Number44.9946.3237.2756
Pretty Stable
Shareholders Equity Per Share26.0723.3723.2371
Very volatile
Debt To Equity0.01050.01070.0098
Pretty Stable
Average Receivables4.5 M4.2 M2.3 M
Slightly volatile
Revenue Per Share0.240.190.5638
Slightly volatile
Interest Debt Per Share0.230.210.2337
Slightly volatile
Debt To Assets0.01040.01050.0097
Pretty Stable
Enterprise Value Over EBITDA8.039.049.8632
Slightly volatile
Operating Cycle18.3519.32204
Pretty Stable
Price Book Value Ratio1.00.910.9166
Very volatile
Company Equity Multiplier1.111.151.0218
Slightly volatile
Total Debt To Capitalization0.01040.01060.0097
Pretty Stable
Debt Equity Ratio0.01050.01070.0098
Pretty Stable
Quick Ratio0.470.56.6458
Very volatile
Cash Ratio0.00.00.054
Very volatile
Cash Conversion Cycle18.3519.32204
Pretty Stable
Days Of Sales Outstanding18.3519.32204
Pretty Stable
Price To Book Ratio1.00.910.9166
Very volatile
Enterprise Value Multiple8.039.049.8632
Slightly volatile
Debt Ratio0.01040.01050.0097
Pretty Stable
Price Sales Ratio17489.35129
Very volatile
Asset Turnover0.0110.00910.027
Slightly volatile
Price Fair Value1.00.910.9166
Very volatile

Tekla Healthcare Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1 B962.2 M963.4 M
Pretty Stable
Enterprise Value1 B962.2 M963.6 M
Pretty Stable

Tekla Fundamental Market Drivers

About Tekla Healthcare Financial Statements

Investors use fundamental indicators, such as Tekla Healthcare's revenue or net income, to determine how well the company is positioned to perform in the future. Although Tekla Healthcare's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Total Revenue114.8 M120.5 M
Cost Of Revenue12.1 M7.4 M
Sales General And Administrative To Revenue 1.17  1.94 
Revenue Per Share 0.19  0.24 
Ebit Per Revenue(0.02)(0.02)

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether Tekla Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tekla Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tekla Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tekla Healthcare Investors Stock:
How To Invest In Tekla
Details
Is Tekla Stock a good investment?
Details
What is Tekla Healthcare's Net Worth?
Details
Largest Asset Management & Custody Banks Companies
View
Largest Financial Services Companies
View
Check out the analysis of Tekla Healthcare Correlation against competitors.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is there potential for Asset Management & Custody Banks market expansion? Will Tekla introduce new products? Factors like these will boost the valuation of Tekla Healthcare. Market participants price Tekla higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.911
Dividend Share
2.24
Earnings Share
1.61
Revenue Per Share
0.136
Quarterly Revenue Growth
(0.49)
Tekla Healthcare Inv's market price often diverges from its book value, the accounting figure shown on Tekla's balance sheet. Smart investors calculate Tekla Healthcare's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Tekla Healthcare's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY